Laccase-based biocatalytic systems application in sustainable degradation of pharmaceutically active contaminants
Применение биокаталитических систем на основе лакказы для устойчивой деградации фармацевтически активных загрязнителей
2024-12-06
SCID: 54.1/9x2m2bhm
Discuss with AI
antibiotic resistancecomputer-assisted binding predictionenzymatic bioremediationlaccase immobilizationpharmaceutical contaminants
Figures from the paper
Abstract (AI)
The outflow of pharmaceutically active chemicals (PhACs) exerts a negative impact on biological systems even at extremely low concentrations. For instance, enormous threats to human and aquatic species have resulted from the widespread use of antibiotics in ecosystems, which stimulate the emergence and formation of antibiotic-resistant bacterial species and associated genes. Additionally, it is challenging to eliminate these PhACs by employing conventional physicochemical water treatment techniques. Enzymatic approaches, including laccase , have been identified as a promising alternative to eliminate a broad array of PhACs from water matrices. However, their application in environmental bioremediation is hindered by several factors, including the enzyme's stability and its location in the aqueous environment. Such obstacles may be surmounted by employing laccase immobilization, which enables enhanced stability (including inactivation caused by the substrate), and thus improved catalysis. This review emphasizes the potential hazards of PhACs to aquatic organisms within the detection concentration range of ngL −1 to µgL −1 , as well as the deployment of laccase-based multifunctional biocatalytic systems for the environmentally friendly mitigation of anticancer drugs , analgesics/NSAIDs, antibiotics, antiepileptic agents , and beta blockers as micropollutants. This approach could reduce the underlying toxicological consequences. In addition, current developments, potential applications, and viewpoints have focused on computer-assisted investigations of laccase-PhACs binding at enzyme cavities and degradability prediction.
Key Findings
1
Computer-assisted studies of laccase–pharmaceutical binding and degradability prediction are emerging tools for optimizing biocatalytic treatment systems.
2
Conventional physicochemical water-treatment methods face challenges in removing diverse pharmaceutical contaminants from water matrices.
3
Laccase immobilization can improve enzyme stability, reduce substrate-induced inactivation, and enhance catalytic performance during environmental remediation.
4
Laccase-based enzymatic systems offer a promising alternative for degrading anticancer drugs, analgesics/NSAIDs, antibiotics, antiepileptics, and beta blockers.
5
Pharmaceutically active contaminants can harm aquatic and human biological systems at concentrations ranging from ng L−1 to µg L−1.
Research Object
Pharmaceutically active contaminants (PhACs) in water matrices, including anticancer drugs, analgesics/NSAIDs, antibiotics, antiepileptic agents, and beta blockers
Research Subject
Laccase-based biocatalytic degradation and mitigation of PhACs, including enzyme immobilization, stability, catalytic performance, and laccase–PhAC binding and degradability
Publication Details
Publication Date
2024-12-06
Journal
Publisher
ISSN
Cited by
57
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai6
Laccase Properties, Physiological Functions, and Evolution2020
Laccases: structure, function, and potential application in water bioremediation2019
Laccases: Production, Expression Regulation, and Applications in Pharmaceutical Biodegradation2017
A structural-chemical explanation of fungal laccase activity2018
Fungal Laccases: Fundamentals, Engineering and Classification Update2023
Substitution of the Methionine Axial Ligand of the T1 Copper for the Fungal-like Phenylalanine Ligand (M298F) Causes Local Structural Perturbations that Lead to Thermal Instability and Reduced Catalytic Efficiency of the Small Laccase from Streptomyces coelicolor A3(2)2022